Studies in PC3 prostate cancer cells have shown that WISP1-induced β-catenin signaling has been linked to HAS2 transcription, suggesting a coordinated regulation of hyaluronan metabolism and MMP activity during ECM remodeling [67]. This evidence concerns the gene HAS2 and prostate carcinoma.